How big Is stss selling potential worldwide further

Sharps Technology's (STSS) selling potential worldwide is significant, driven by several factors:

1. Increasing Demand for Smart Syringes: The global market for smart syringes is expected to grow significantly, driven by increasing awareness of healthcare safety, regulations promoting safe injection practices, and the need to prevent needle-stick injuries and infections like HIV and hepatitis.
2. Strategic Partnerships and Agreements: Sharps Technology has secured strategic agreements, such as a five-year, $200 million syringe Sales Agreement, which underscores the demand for its products and provides substantial revenue visibility. The company has also sold out production capacity for its SoloGard product, indicating strong market demand.
3. Upgraded Manufacturing Capabilities: The company's upgraded manufacturing facility in Hungary, equipped with advanced molding and automation technologies, positions it to meet the anticipated increase in demand. This facility expansion and technological advancements support the company's ability to scale production and meet global demand.
4. Market Positioning: Sharps Technology's portfolio of smart safety syringes, including the SecureGard and SoloGard products, is well-positioned to capitalize on the growing demand for safer injection practices and minimally invasive procedures.
5. Global Focus on Infection Control: The global focus on reducing infections and improving healthcare safety, as seen in the response to the COVID-19 pandemic, is driving the adoption of safer medical devices like smart syringes.

Considering these factors, Sharps Technology's selling potential worldwide is substantial, with the company well-positioned to capitalize on the growing demand for its innovative products.